Kura Oncology, Inc.·4

Jan 4, 4:07 PM ET

Powl Brian T. 4

4 · Kura Oncology, Inc. · Filed Jan 4, 2024

Insider Transaction Report

Form 4
Period: 2024-01-02
Powl Brian T.
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2024-01-02+15,00015,000 total
  • Award

    Option to purchase common stock

    2024-01-02+30,00030,000 total
    Exercise: $15.36Exp: 2034-01-01Common Stock (30,000 underlying)
Footnotes (2)
  • [F1]Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/25, 1/26/26, 1/26/27 and 1/26/28.
  • [F2]This option vests in 48 equal monthly installments commencing on the grant date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4